Journal of Investigative Medicine High Impact Case Reports (Jul 2022)

Case of Primary Hepatic Angiosarcoma Presenting With Jaundice and Infiltrative Liver Masses

  • Adnan Shaaban MD,
  • Chimaobi Anugwom MBBS,
  • Alma Habib MD,
  • Tetyana Mettler MD,
  • Shahid Jaffer MD,
  • Mary Thomson MD

DOI
https://doi.org/10.1177/23247096221111768
Journal volume & issue
Vol. 10

Abstract

Read online

Primary hepatic angiosarcoma (PHA) is a rare and aggressive mesenchymal liver tumor with a poor prognosis and high mortality. Treatment options are limited to palliative chemotherapy with surgical resection reserved for the few cases that present early. We present a case of a patient who presented with jaundice and elevated liver enzymes. Imaging identified a diffusely heterogeneous liver consistent with cirrhosis, findings of portal hypertension, and 2 ill-defined liver lesions. Biopsy results confirmed PHA. Primary hepatic angiosarcoma does not have a typical presentation but should be considered for any patient presenting with an infiltrative liver mass.